
OM 369 Syrup
August 8, 2019Linzodin Syrup
August 8, 2019LINZOLIDE
CLEAR CHOICE TO TREAT INFECTIONS CAUSED BY MRSA
OFFERS A FAVORABLE SAFETY PROFILE IN A BROAD RANGE OF PATIENTS
Exhibits good activity against Staphylococci including strains resistant to Methicillin Glycopeptides & other antibacterial agents. Highly active against penicillin resistant S. Pneumonaei, Vancomycin-resistant E.Faecalis, Corynebacterium Sp, Moraxella Catarrhalis and Bacteroides Fragilis. Excellent option with significant resistant gram positive bacteremic infections. Safe and efficacious for Nosocomial Pneumonia.
INDICATIONS :
- CAP
- UTI
- SSTI
- BACTERAEMIA
- DIABETIC FOOT INFECTIONS
- BONE & BONE MARROW INFECTIONS
DOSAGE & ADMINISTRATION:
Adults : 1 Tab (400 mg / 600 mg) twice a day for 10-14 days.
Children <12 Years : 20 mg – 30 mg / kg body weight in 2 divided doses in a day for 10-14 days.
MRP Rs. 1600
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.